About: Florence Duffaud

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Florence Duffaud Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Duffaud, Florence (1967-....) Duffaud, Florence (1967-....)
Life Event	http://www.idref.fr/137396767/birth
preferred label	Duffaud, Florence (1967-....)
name	Florence Duffaud
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	000000035750320X
Given name	Florence
familyName	Duffaud
has biographical i...tion (Deprecated)	Médecin. Directeur de thèse. Née le 4 février 1967 à Sallanches.Thèse d'université soutenue le 31 janvier 1997 à Marseille.
gender	female
Scopus ID	7003586266
is sameAs of	Duffaud, Florence (1967-....) Duffaud, Florence (1967-....) Duffaud, Florence (1967-....)
is Thesis advisor of	http://www.sudoc.fr/053691202/id http://www.sudoc.fr/19946586X/id http://www.sudoc.fr/145572544/id http://www.sudoc.fr/137397496/id
is Praeses of	http://www.sudoc.fr/183948521/id http://www.sudoc.fr/236617834/id
is Author of	http://www.sudoc.fr/041945360/id http://www.sudoc.fr/041539842/id Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) http://www.sudoc.fr/245620702/id https://serval.unil.ch/notice/serval:BIB_0237CD1F1953#id CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment Surgery in reference centers improves survival of sarcoma patients: a nationwide study Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF) Applications \"in vitro\" et \"in vivo\", en cancérologie clinique, du test de numération des micronoyaux dans les lymphocytes T binucléés en culture https://serval.unil.ch/notice/serval:BIB_73A4901D503F#id Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy Surrogate endpoints in advanced sarcoma trials: a meta-analysis Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts). Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study Determinants of the access to remote specialised services provided by national sarcoma reference centres Determinants of favourable opinions about euthanasia in a sample of French physicians Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial https://serval.unil.ch/notice/serval:BIB_0CA50030FA6A#id EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study https://serval.unil.ch/notice/serval:BIB_D3357AC4FE51#id The off-label use of targeted therapies in sarcomas: the OUTC’S program No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome? Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)
is primary topic of	http://www.idref.fr/137396767
is Opponent of	http://www.sudoc.fr/237806797/id
is Thesis referee of	http://www.sudoc.fr/172407141/id http://www.sudoc.fr/152162844/id http://www.sudoc.fr/259156698/id http://www.sudoc.fr/257617167/id http://www.sudoc.fr/257670076/id

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software